INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Qingdao, China.
Research context
INKON Life Technology Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
INKON Life Technology Co., Ltd is currently in a long term downtrend where the price is trading 4.7% below its 200 day moving average.
From a valuation standpoint, the stock is 159.2% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 17.6.
INKON Life Technology Co., Ltd's total revenue rose by 38.8% to $204M since the same quarter in the previous year.
Its net income has increased by 1.1% to $16M since the same quarter in the previous year.
Finally, its free cash flow grew by 162.3% to $42M since the same quarter in the previous year.
Based on the above factors, INKON Life Technology Co., Ltd gets an overall score of 3/5.